Rapid Point-of-Care Testing Technology and Application
A special issue of Chemosensors (ISSN 2227-9040). This special issue belongs to the section "(Bio)chemical Sensing".
Deadline for manuscript submissions: 30 September 2024 | Viewed by 805
Special Issue Editors
Interests: diagnostic and therapeutic methods; microfluidics; biosensors
Special Issues, Collections and Topics in MDPI journals
Interests: analytical chemistry; statistics; diagnostics
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
It is a great honour to invite you to contribute to this Special Issue, entitled "Rapid Point-of-Care Testing Technology and Application". Since the first developed system in 1972 and the introduction of the term in the early 1980s, POCT has been widely accepted as a viable and valuable alternative to traditional laboratory-based testing, especially when rapid medical decisions are required or in low-resource and remote settings. Nevertheless, researchers are continuously involved in the process of understanding how new micro- and nanotechnologies could further improve traditional POCT diagnostics. With researchers' contributions to developing new ways of detecting target analytes at small volumes, POCT will be ASSURED (affordable, sensitive, specific, user-friendly, rapid and robust, equipment-free and deliverable to end-users). Eventually, POCT will become an essential tool that can significantly contribute to reduced morbidity, mortality and an increased quality of life. Therefore, we invite you to submit your research studies and help bring POCT to the next level: personalised active disease management.
Dr. Florina S. Iliescu
Dr. Zenovia Moldovan
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Chemosensors is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- POCT
- diagnostic
- microfluidics
- biosensors
- antibody
- immune response
- prophylaxis
Planned Papers
The below list represents only planned manuscripts. Some of these manuscripts have not been received by the Editorial Office yet. Papers submitted to MDPI journals are subject to peer-review.
Title: Minimising phase errors in synchronous demodulation bioimpedance sensing
Authors: Ifeabunike Nwokoye,; Iasonas Triantis.
Affiliation: Research Centre for Biomedical Engineering, City, University of London, London EC1V 0HB, UK
Abstract: Bioimpedance sensing provides crucial biomedical insights, ranging from body composition analysis, diagnostics, hydration, and foetal monitoring to tissue characterisation. Its versatility includes applications in cardiovascular monitoring, wearables, rehabilitation tracking, and smart prosthetics, advancing personalised healthcare and research. Among the several bioimpedance instrumentation topologies synchronous demodulation (SD) stands out for its ability to extract both real and imaginary components with similar accuracy, whilst allowing for multi-frequency measurements and frequency sweeping. Nonetheless, phase shifts introduced at the signal generation stage can significantly impact diagnostic accuracy in applications reliant on precise tissue phase profiling, such as cancer detection and neuromuscular evaluations. In this paper, we present the design and experimental assessment of an automatic phase compensation system to significantly increase bioimpedance sensing accuracy. A significant reduction in phase error from 20% to below 5% is demonstrated at the higher end of the operating bandwidth, an improvement that can be game changing for enhancing the accuracy of tumour detection characterisation, amongst other applications.
